Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Abvc Biopharma (ABVC) over the last 12 years, with Q3 2025 value amounting to $1.1 million.

  • Abvc Biopharma's Other Operating Expenses rose 108510.25% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 16296.58%. This contributed to the annual value of $2.8 million for FY2024, which is 139164.48% up from last year.
  • As of Q3 2025, Abvc Biopharma's Other Operating Expenses stood at $1.1 million, which was up 108510.25% from $1.6 million recorded in Q2 2025.
  • Abvc Biopharma's Other Operating Expenses' 5-year high stood at $4.4 million during Q4 2021, with a 5-year trough of -$1.2 million in Q4 2023.
  • Its 5-year average for Other Operating Expenses is $694338.1, with a median of $282875.0 in 2024.
  • Per our database at Business Quant, Abvc Biopharma's Other Operating Expenses soared by 63422000.0% in 2021 and then tumbled by 16465.11% in 2023.
  • Quarter analysis of 5 years shows Abvc Biopharma's Other Operating Expenses stood at $4.4 million in 2021, then crashed by 56.77% to $1.9 million in 2022, then tumbled by 164.65% to -$1.2 million in 2023, then skyrocketed by 129.66% to $363079.0 in 2024, then skyrocketed by 212.94% to $1.1 million in 2025.
  • Its Other Operating Expenses was $1.1 million in Q3 2025, compared to $1.6 million in Q2 2025 and $48773.0 in Q1 2025.